High Pointe Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$782K |
| 2 |
SRCL
Stericycle Inc
SRCL
|
+$582K |
| 3 |
AstraZeneca
AZN
|
+$493K |
| 4 |
Qualcomm
QCOM
|
+$397K |
| 5 |
NVO
Novo Nordisk
NVO
|
+$352K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Jones Lang LaSalle
JLL
|
+$1.34M |
| 2 |
Starbucks
SBUX
|
+$1.28M |
| 3 |
Sempra
SRE
|
+$1.15M |
| 4 |
Zoetis
ZTS
|
+$1M |
| 5 |
Apple
AAPL
|
+$819K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.02% |
| 2 | Financials | 18.24% |
| 3 | Technology | 11.59% |
| 4 | Communication Services | 9.9% |
| 5 | Industrials | 9.87% |
Similar funds
High Pointe Capital Management's Q2 2018 Portfolio in Review
As of Q2 2018, High Pointe Capital Management held 92 positions worth $70.1M, down 3.6% from $72.8M the previous quarter. Its ten largest holdings account for 26% of the portfolio.
High Pointe Capital Management withdrew a net $4.75M in Q2 2018, closing 11 positions and reducing 38 holdings. Its most notable exit was Jones Lang LaSalle, an estimated $1.34M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 18% a quarter earlier, followed by Financials and Technology.
Against the trend, High Pointe Capital Management opened a new position in Regeneron Pharmaceuticals worth $862K.
- High Pointe Capital Management's largest Q2 2018 buy was Regeneron Pharmaceuticals: 2,500 shares worth $862K.
- High Pointe Capital Management added most to AstraZeneca in Q2 2018, an estimated $493K increase.
- High Pointe Capital Management's biggest Q2 2018 reduction was Alphabet (Google) Class C, cutting an estimated $75.6K.
- High Pointe Capital Management fully exited Jones Lang LaSalle in Q2 2018, selling an estimated $1.34M.
- High Pointe Capital Management's ten largest holdings make up 26% of its $70.1M portfolio in Q2 2018.
- High Pointe Capital Management opened 5 new positions and closed 11 in Q2 2018.
- High Pointe Capital Management's portfolio value fell 3.6% quarter-over-quarter to $70.1M.
Based on High Pointe Capital Management's 13F filing for Q2 2018, filed 8 Aug 2018.